Cargando…
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking
BACKGROUND: Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stopping. CD therefore serves as a timely and novel paradigm...
Autores principales: | Whitwell, Sophia CL, Mathew, Christopher G, Lewis, Cathryn M, Forbes, Alastair, Watts, Sally, Sanderson, Jeremy, Hollands, Gareth J, Prevost, A Toby, Armstrong, David, Kinmonth, Ann Louise, Sutton, Stephen, Marteau, Theresa M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036624/ https://www.ncbi.nlm.nih.gov/pubmed/21247480 http://dx.doi.org/10.1186/1471-2458-11-44 |
Ejemplares similares
-
Effect of communicating DNA based risk assessments for Crohn’s disease on smoking cessation: randomised controlled trial
por: Hollands, Gareth J, et al.
Publicado: (2012) -
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence
por: Marteau, Theresa M, et al.
Publicado: (2010) -
Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial
por: Marteau, Theresa M., et al.
Publicado: (2012) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol
por: Mann, Eleanor, et al.
Publicado: (2009) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial
por: Marteau, Theresa M, et al.
Publicado: (2010)